Between now and later: a mixed methods study of HPV vaccination delay among Chinese caregivers in urban Chengdu, China.
Cervical cancer
China
Human papillomavirus
Mixed methods
Vaccine delay
Journal
BMC public health
ISSN: 1471-2458
Titre abrégé: BMC Public Health
Pays: England
ID NLM: 100968562
Informations de publication
Date de publication:
15 Jan 2024
15 Jan 2024
Historique:
received:
25
05
2023
accepted:
08
01
2024
medline:
16
1
2024
pubmed:
16
1
2024
entrez:
15
1
2024
Statut:
epublish
Résumé
Adolescent girls in China have a low HPV vaccination rate. Although vaccination is recommended by the Chinese health authorities, the cost is not covered by the national immunisation programme. Vaccination delay, among other reasons such as supply shortage and poor affordability, may contribute to low uptake. This sequential mixed methods study aimed to identify potential factors of delayed HPV vaccination among Chinese adolescent girls. Quantitative data about the attitudes and perceptions of HPV vaccination were collected from 100 caregivers of 14-18-year-old girls using an online survey in Chengdu, China. The survey data informed a subsequent qualitative study using four focus group discussions. We conducted a descriptive analysis of the survey data and a thematic analysis of the qualitative data. The findings were interpreted using a health behaviour model adapted from the Health Belief Model and the Andersen's Behavioural Model for Health Services Use. A total of 100 caregivers - 85 were mothers and 15 were fathers - participated in the survey; 21 caregivers joined focus group discussions. When asked about their intended course of action if the 9vHPV vaccine was out-of-stock, 74% chose to delay until the 9vHPV vaccine is available while 26% would consider 2vHPV or 4vHPV vaccines or seek alternative ways to procure the vaccine. Qualitative results confirmed that caregivers preferred delaying HPV vaccination for adolescent girls. The intent to delay was influenced by systemic barriers such as supply shortage and individual-level factors such as a preference for the 9vHPV vaccine, safety concerns, inadequate health communication, and the belief that adolescents were unlikely to be sexually active. In urban areas, Chinese caregivers' intent to delay vaccination in favour of 9vHPV vaccine over receiving the more accessible options was influenced by a mix of individual and contextual factors. Focussed health communication strategies are needed to accelerate HPV vaccination among adolescents.
Sections du résumé
BACKGROUND
BACKGROUND
Adolescent girls in China have a low HPV vaccination rate. Although vaccination is recommended by the Chinese health authorities, the cost is not covered by the national immunisation programme. Vaccination delay, among other reasons such as supply shortage and poor affordability, may contribute to low uptake. This sequential mixed methods study aimed to identify potential factors of delayed HPV vaccination among Chinese adolescent girls.
METHODS
METHODS
Quantitative data about the attitudes and perceptions of HPV vaccination were collected from 100 caregivers of 14-18-year-old girls using an online survey in Chengdu, China. The survey data informed a subsequent qualitative study using four focus group discussions. We conducted a descriptive analysis of the survey data and a thematic analysis of the qualitative data. The findings were interpreted using a health behaviour model adapted from the Health Belief Model and the Andersen's Behavioural Model for Health Services Use.
RESULTS
RESULTS
A total of 100 caregivers - 85 were mothers and 15 were fathers - participated in the survey; 21 caregivers joined focus group discussions. When asked about their intended course of action if the 9vHPV vaccine was out-of-stock, 74% chose to delay until the 9vHPV vaccine is available while 26% would consider 2vHPV or 4vHPV vaccines or seek alternative ways to procure the vaccine. Qualitative results confirmed that caregivers preferred delaying HPV vaccination for adolescent girls. The intent to delay was influenced by systemic barriers such as supply shortage and individual-level factors such as a preference for the 9vHPV vaccine, safety concerns, inadequate health communication, and the belief that adolescents were unlikely to be sexually active.
CONCLUSION
CONCLUSIONS
In urban areas, Chinese caregivers' intent to delay vaccination in favour of 9vHPV vaccine over receiving the more accessible options was influenced by a mix of individual and contextual factors. Focussed health communication strategies are needed to accelerate HPV vaccination among adolescents.
Identifiants
pubmed: 38225563
doi: 10.1186/s12889-024-17697-6
pii: 10.1186/s12889-024-17697-6
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
183Subventions
Organisme : Bill & Melinda Gates Foundation
ID : INV-034554
Pays : United States
Organisme : Bill & Melinda Gates Foundation
ID : INV-034554
Pays : United States
Organisme : Bill & Melinda Gates Foundation
ID : INV-034554
Pays : United States
Organisme : NIH HHS
ID : NIH NIAID R01AI158826
Pays : United States
Informations de copyright
© 2024. The Author(s).
Références
Bruni L, Albero G, Serrano B, Mena M, Collado J, Gómez D, et al. Human Papillomavirus and Related Diseases in China. Summary Report. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). 2021. Available from: www.hpvcentre.com .
Zou Z, Fairley CK, Ong JJ, Hocking J, Canfell K, Ma X, et al. Domestic HPV vaccine price and economic returns for cervical cancer prevention in China: a cost-effectiveness analysis. Lancet Glob Heal. 2020;8(10):e1335-44. Available from: https://doi.org/10.1016/S2214-109X(20)30277-1 .
doi: 10.1016/S2214-109X(20)30277-1
World Health Organization. Global strategy to accelerate the elimination of cervical cancer as a public health problem, United Nations General Assembly. Geneva; 2021; 2 Available from: https://www.who.int/publications/i/item/9789240014107 .
Ji L, Chen M, Yao L. Strategies to eliminate cervical cancer in China. Front Oncol. 2023;13:1105468. Available from: https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1105468/full#B50 .
You D, Han L, Li L, Hu J, Zimet GD, Alias H, et al. Human Papillomavirus (HPV) Vaccine Uptake and the Willingness to Receive the HPV Vaccination among Female College Students in China: A Multicenter Study. Vaccines. 2020;8(31):1–19 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7157221/ .
Wang D, Wu J, Du J, Ong H, Tang B, Dozier M, et al. Acceptability of and barriers to human papillomavirus vaccination in China: A systematic review of the Chinese and English scientific literature. Eur J Cancer Care. 2022;31(3):e13566 http://www.ncbi.nlm.nih.gov/pubmed/35229931 .
doi: 10.1111/ecc.13566
People’s Government of Xinjin District Chengdu [成都市新津區人民政府]. Do not blindly wait for 9vHPV vaccines! Experts: Get vaccinated earlier and younger. [不要盲目等“九价”!专家: 接种HPV疫苗应尽早、尽小]. District Health Bureau [區衛健局]. 2022 [Cited 2023 Aug 13]. Available from: http://www.xinjin.gov.cn/xjxrmzf/c135373/2022-01/14/content_c6fbe44313fe40d4b228b6d2e356b40e.shtml .
Tang W. Increasing mainland China HPV vaccine uptake: domestic 2vHPV vaccine gaining market dominance, 9vHPV vaccines in the pipeline. [国内HPV疫苗可及性加速提升: 二价市场国产占优, 九价在研产品多]. Sina News. 2022 [Cited 2022 Dec 3]. Available from: https://finance.sina.com.cn/chanjing/cyxw/2022-05-31/doc-imizirau5859918.shtml .
Burger EA, Portnoy A, Campos NG, Sy S, Regan C, Kim JJ. Choosing the optimal HPV vaccine: The health impact and economic value of the nonavalent and bivalent HPV vaccines in 48 Gavi-eligible countries. Int J Cancer. 2021;148(4):932–40. https://doi.org/10.1002/ijc.33233 .
doi: 10.1002/ijc.33233
pubmed: 32706907
Pan XF, Li R, Pan A, Larson H. Human papillomavirus vaccine approval in China: a major step forward but challenges ahead. Lancet Infect Dis. 2016;16(12):1322–3. https://doi.org/10.1016/S1473-3099(16)30450-9 .
doi: 10.1016/S1473-3099(16)30450-9
pubmed: 27998583
Zhao F, Qiao Y. Cervical cancer prevention in China: a key to cancer control. Lancet. 2019;393(10175):969–70. https://doi.org/10.1016/S0140-6736(18)32849-6 .
doi: 10.1016/S0140-6736(18)32849-6
pubmed: 30860036
Zhou F, Zhang W, Cai H, Cao Y. Portrayals of 2v, 4v and 9vHPV vaccines on Chinese social media: a content analysis of hot posts on Sina Weibo. Hum Vaccin Immunother. 2021;17(11):4433–41. https://doi.org/10.1080/21645515.2021.1971016 .
doi: 10.1080/21645515.2021.1971016
pubmed: 34543155
pmcid: 8828098
Li M. Increasing Age Eligibility of 9vHPV Exacerbates Vaccine Shortage. [九价HPV疫苗扩龄 供不应求或加剧]. Sina News. 2022 [Cited 2022 Dec 3]. Available from: https://finance.sina.com.cn/chanjing/cyxw/2022-09-01/doc-imiziraw0702333.shtml .
Zhang N. It’s already 2022, why is it so hard to get the HPV vaccine? [都2022年了, HPV疫苗为啥还那么难抢?]. Huanqiu.com. [環球網]. 2022 [Cited 2022 Mar 28]. Available from: https://china.huanqiu.com/article/46Ng3eHB6rH .
Wu Y. 9-valent HPV vaccine in short supply, domestric vaccines to arrive on market soon. [九价宫颈癌疫苗紧俏 一大波国产HPV疫苗正竞速上市] . Wuhan News. [武汉晚报]. 2021 [Cited 2022 Mar 28]. Available from: https://news.cctv.com/2021/10/18/ARTIZA2uOtM6IrLLeHGYhSfW211018.shtml .
Siu JYM, Fung TKF, Leung LHM. Social and cultural construction processes involved in HPV vaccine hesitancy among Chinese women: A qualitative study. Int J Equity Health. 2019;18(1):1–18. https://doi.org/10.1186/s12939-019-1052-9 .
doi: 10.1186/s12939-019-1052-9
Larson HJ, Gakidou E, Murray CJL. The Vaccine-Hesitant Moment. N Engl J Med. 2022;387:58–65 https://www.nejm.org/doi/full/10.1056/NEJMra2106441 .
doi: 10.1056/NEJMra2106441
pubmed: 35767527
Larson HJ. Defining and measuring vaccine hesitancy. Nat Hum Behav. 2022;6:1609–10. https://doi.org/10.1038/s41562-022-01484-7 .
Zhang Y, Wang Y, Liu L, Fan Y, Liu Z, Wang Y, et al. Awareness and knowledge about human papillomavirus vaccination and its acceptance in China: A meta-analysis of 58 observational studies. BMC Public Health. 2016;16(1):1–15. https://doi.org/10.1186/s12889-016-2873-8 .
doi: 10.1186/s12889-016-2873-8
Wang W, Ma Y, Wang X, Zou H, Zhao F, Wang S, et al. Acceptability of human papillomavirus vaccine among parents of junior middle school students in Jinan, China. Vaccine. 2015;33(22):2570–6. https://doi.org/10.1016/j.vaccine.2015.04.010 .
doi: 10.1016/j.vaccine.2015.04.010
pubmed: 25887088
Lin Y, Su Z, Chen F, Zhao Q, Zimet GD, Alias H, et al. Chinese mothers’ intention to vaccinate daughters against human papillomavirus (HPV), and their vaccine preferences: a study in Fujian Province. Hum Vaccines Immunother. 2021;17(1):304–15. https://doi.org/10.1080/21645515.2020.1756152 .
doi: 10.1080/21645515.2020.1756152
Zhang SK, Pan XF, Wang SM, Yang CX, Gao XH, Wang ZZ, et al. Knowledge of human papillomavirus vaccination and related factors among parents of young adolescents: A nationwide survey in China. Ann Epidemiol. 2015;25(4):231–5. https://doi.org/10.1016/j.annepidem.2014.12.009 .
doi: 10.1016/j.annepidem.2014.12.009
pubmed: 25656922
Wei Z, Liu Y, Zhang L, Sun X, Jiang Q, Li Z, et al. Stages of HPV Vaccine Hesitancy Among Guardians of Female Secondary School Students in China. J Adolesc Heal. 2023;72(1):73–9. https://doi.org/10.1016/j.jadohealth.2022.08.027 .
doi: 10.1016/j.jadohealth.2022.08.027
Wang J, Ji Q, Dong S, Zhao S, Li X, Zhu Q, et al. Factors influencing vaccine hesitancy in China: A qualitative study. Vaccines. 2021;9(11):1–12 https://www.mdpi.com/2076-393X/9/11/1291 .
doi: 10.3390/vaccines9111291
Gilkey MB, Calo WA, Marciniak MW, Brewer NT. Parents who refuse or delay HPV vaccine: Differences in vaccination behavior, beliefs, and clinical communication preferences. Hum Vaccines Immunother. 2017;13(3):680–6 https://www.tandfonline.com/doi/full/10.1080/21645515.2016.1247134 .
doi: 10.1080/21645515.2016.1247134
Ivankova NV, Creswell JW, Stick SL. Using Mixed-Methods Sequential Explanatory Design: From Theory to Practice. Field methods. 2006;18(1):3–108 https://journals-sagepub-com.ez.lshtm.ac.uk/doi/epdf/10.1177/1525822X05282260 .
doi: 10.1177/1525822X05282260
Chengdu Daily. By the end of 2021, the population in Chengdu will reach 21.192 million. [2021年末成都市常住人口达2119.2万]. Chengdu Municipal Development and Reform Commission. 2022 [Cited 2022 Jul 25]. Available from: http://cddrc.chengdu.gov.cn/cdfgw/fzggdt/2022-03/15/content_9a3e765c5dc942f2a09fbbed27f23b41.shtml .
China Daily. Nation plans to launch free HPV vaccinations. National Health Commission of the People’s Republic of China. 2022. Available from: http://en.nhc.gov.cn/2022-01/14/c_85612.htm . Cited 2022 Aug 16.
Li Y, Qin C, Qiu S, He Y, Pang L, Xu X, et al. The effectiveness of pay-it-forward in addressing HPV vaccine delay and increasing uptake among 15–18-year-old adolescent girls compared to user-paid vaccination: a study protocol for a two-arm randomized controlled trial in China. BMC Public Health. 2023;23(1):1–10. https://doi.org/10.1186/s12889-022-14947-3 .
doi: 10.1186/s12889-022-14947-3
Wu D, Jin C, Bessame K, Tang FFY, Ong JJ, Wang Z, et al. Effectiveness of a pay-it-forward intervention compared with user-paid vaccination to improve influenza vaccine uptake and community engagement among children and older adults in China: a quasi-experimental pragmatic trial. Lancet Infect Dis. 2022;22(10):1484–92. https://doi.org/10.1016/S1473-3099(22)00346-2 .
doi: 10.1016/S1473-3099(22)00346-2
pubmed: 35868342
pmcid: 9492551
Chen H, Li X, Gao J, Liu X, Mao Y, Wang R, et al. Health belief model perspective on the control of covid-19 vaccine hesitancy and the promotion of vaccination in china: Web-based cross-sectional study. J Med Internet Res. 2021;23(9):e29329 https://www.jmir.org/2021/9/e29329 .
doi: 10.2196/29329
pubmed: 34280115
pmcid: 8425399
Wong MCS, Wong ELY, Huang J, Cheung AWL, Law K, Chong MKC, et al. Acceptance of the COVID-19 vaccine based on the health belief model: A population-based survey in Hong Kong. Vaccine. 2021;39(7):1148–56. https://doi.org/10.1016/j.vaccine.2020.12.083 .
doi: 10.1016/j.vaccine.2020.12.083
pubmed: 33461834
pmcid: 7832076
LaMorte WW. The Health Belief Model. Boston University School of Public Health. 2019 [Cited 2022 Jul 14]. Available from: https://sphweb.bumc.bu.edu/otlt/mph-modules/sb/behavioralchangetheories/behavioralchangetheories2.html .
Jones CL, Jensen JD, Scherr CL, Brown NR, Christy K, Weaver J. The Health Belief Model as an Explanatory Framework in Communication Research: Exploring Parallel, Serial, and Moderated Mediation. Heal Commun. 2015;30(6):566–76 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530978/ .
doi: 10.1080/10410236.2013.873363
Dang JHT, Stewart SL, Blumberg DA, Rodriguez HP, Chen MS. “There’s Always Next Year”: Primary Care Team and Parent Perspectives on the Human Papillomavirus Vaccine. Hum Vaccines Immunother. 2020;16(8):1814–23 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7484906/ .
doi: 10.1080/21645515.2019.1710410
Gelberg L, Andersen RM, Leake BD. The Behavioral Model for Vulnerable Populations: application to medical care use and outcomes for homeless people. Health Serv Res. 2000;34(6):1273–302 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1089079/ .
pubmed: 10654830
pmcid: 1089079
Babitsch B, Gohl D, Von Lengerke T. Re-revisiting Andersen’s Behavioral Model of Health Services Use: a systematic review of studies from 1998–2011. Pyschosocial Med. 2012;9:Doc11 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488807/ .
Braun V, Clarke V. Can I use TA? Should I use TA? Should I not use TA? Comparing reflexive thematic analysis and other pattern-based qualitative analytic approaches. Couns Psychother Res. 2021;21(1):37–47. https://doi.org/10.1002/capr.12360 .
doi: 10.1002/capr.12360
The Strategic Advisory Group of Experts on Immunization (SAGE). Report of the SAGE Working Group on Vaccine Hesitancy. World Health Organization. 2014. Available from: https://www.asset-scienceinsociety.eu/sites/default/files/sage_working_group_revised_report_vaccine_hesitancy.pdf .
O’Cathain A, Murphy E, Nicholl J. The quality of mixed methods studies in health services research. Jorunal Heal Serv Res Policy. 2008;13(2):92–8. https://doi.org/10.1258/jhsrp.2007.007074 .
doi: 10.1258/jhsrp.2007.007074
Rendle KA, Leskinen EA. Timing Is Everything: Exploring Parental Decisions to Delay HPV Vaccination. Qual Health Res. 2017;27(9):1380–90 https://pubmed.ncbi.nlm.nih.gov/27557924/ .
doi: 10.1177/1049732316664499
pubmed: 27557924
World Health Organization. HPV Vaccine Communication: Special Considerations for a unique vaccine 2016 update. Who/Ivb/1312. 2016;88.
Kolek CO, Opanga SA, Okalebo F, Birichi A, Kurdi A, Godman B, et al. Impact of Parental Knowledge and Beliefs on HPV Vaccine Hesitancy in Kenya—Findings and Implications. Vaccines. 2022;10(8):1–18 https://www.mdpi.com/2076-393X/10/8/1185 .
doi: 10.3390/vaccines10081185
Lelliott M, Sahker E, Poudyal H. A Review of Parental Vaccine Hesitancy for Human Papillomavirus in Japan. J Clin Med. 2023;12(5). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10003921/pdf/jcm-12-02004.pdf .
Kobayashi KI, Chanyasanha C, Sujirarat D. Parental decision-making on human papillomavirus vaccination for daughters in Japan. Int J Adolesc Med Health. 2021;33(3):95–105 https://www.degruyter.com/document/doi/10.1515/ijamh-2018-0140/html .
doi: 10.1515/ijamh-2018-0140
Goldstein S, MacDonald NE, Guirguis S, Eskola J, Liang X, Chaudhuri M, et al. Health communication and vaccine hesitancy. Vaccine. 2015;33(34):4212–4. https://doi.org/10.1016/j.vaccine.2015.04.042 .
doi: 10.1016/j.vaccine.2015.04.042
pubmed: 25896382
Wei Z, Liu Y, Zhang L, Sun X, Jiang Q, Li Z, et al. Stages of HPV Vaccine Hesitancy Among Guardians of Female Secondary School Students in China. J Adolesc Heal. 2022;1–7. Available from: https://doi.org/10.1016/j.jadohealth.2022.08.027 .
Fontenot HB, Domush V, Zimet GD. Parental attitudes and beliefs regarding the nine-valent human papillomavirus vaccine. J Adolesc Heal. 2015;57(6):595–600. https://doi.org/10.1016/j.jadohealth.2015.09.003 .
doi: 10.1016/j.jadohealth.2015.09.003
Falcaro M, Castañon A, Ndlela B, Checchi M, Soldan K, Lopez-Bernal J, et al. The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study. Lancet. 2021;398(10316):2084–92. https://doi.org/10.1016/S0140-6736(21)02178-4 .
doi: 10.1016/S0140-6736(21)02178-4
pubmed: 34741816
Foss HS, Oldervoll A, Fretheim A, Glenton C, Lewin S. Communication around HPV vaccination for adolescents in low- and middle-income countries: A systematic scoping overview of systematic reviews. Syst Rev. 2019;8(1):1–15. https://doi.org/10.1186/s13643-019-1100-y .
doi: 10.1186/s13643-019-1100-y
Paul P, Fabio A. Literature review of HPV vaccine delivery strategies: Considerations for school- and non-school based immunization program. Vaccine. 2014;32(3):320–6. https://doi.org/10.1016/j.vaccine.2013.11.070 .
doi: 10.1016/j.vaccine.2013.11.070
pubmed: 24295804
Davies C, Stoney T, Hutton H, Parrella A, Kang M, Macartney K, et al. School-based HPV vaccination positively impacts parents’ attitudes toward adolescent vaccination. Vaccine. 2021;39(30):4190–8. https://doi.org/10.1016/j.vaccine.2021.05.051 .
doi: 10.1016/j.vaccine.2021.05.051
pubmed: 34127299
Liu C-R, Liang H, Zhang X, Pu C, Li Q, Li Q-L, et al. Effect of an educational intervention on HPV knowledge and attitudes towards HPV and its vaccines among junior middle school students in Chengdu, China. BMC Public Health. 2019;19(1):488. https://doi.org/10.1186/s12889-019-6823-0 .
doi: 10.1186/s12889-019-6823-0
pubmed: 31046722
pmcid: 6498581
Zhang X, Liu CR, Wang ZZ, Ren ZF, Feng XX, Ma W, et al. Effect of a school-based educational intervention on HPV and HPV vaccine knowledge and willingness to be vaccinated among Chinese adolescents: a multi-center intervention follow-up study. Vaccine. 2020;38(20):3665–70. https://doi.org/10.1016/j.vaccine.2020.03.032 .
doi: 10.1016/j.vaccine.2020.03.032
pubmed: 32245644